Bentley Pharmaceuticals To Present At The CIBC Annual Biotechnology & Specialty Pharmaceuticals Conference

EXETER, N.H.--(BUSINESS WIRE)--March 16, 2006--Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical and drug delivery company, announced today that Fred Feldman, Ph.D., Vice President of Research and Development and Robert Stote, MD, FACP, Chief Medical Officer, will present at the CIBC Annual Biotechnology & Specialty Pharmaceuticals Conference taking place at the Millennium Broadway Hotel in New York City. Bentley's presentation of "New Drug Delivery Potentials for Treatment of Diabetes" is scheduled for Tuesday, April 4, 2006 at 3:15 p.m. (Eastern Standard Time).